Role of functional imaging in the management of lymphoma
- PMID: 21482982
- DOI: 10.1200/JCO.2010.32.5225
Role of functional imaging in the management of lymphoma
Erratum in
- J Clin Oncol. 2011 Jul 1;29(19):2739
Abstract
18-F-fluorodeoxyglucose (FDG) -positron emission tomography (PET), and more recently PET/computed tomography (CT), is the most sensitive and specific imaging technique currently available for patients with lymphoma. Nevertheless, despite being increasingly used in pretreatment assessment, midtreatment evaluation of response, post-treatment restaging, and surveillance during follow-up of patients with lymphoma, its impact on clinical outcome in most clinical situations remains to be confirmed. PET/CT provides its greatest clinical benefit in the post-treatment evaluation of Hodgkin's lymphoma and diffuse large B-cell lymphoma; however, the role of metabolic imaging in other indications and in other histologies remains to be demonstrated. Ongoing risk-adapted studies will hopefully provide evidence for clinical improvement on the basis of altering treatment as a result of interim PET results. Efforts are ongoing to better standardize the conduct and interpretation of FDG-PET scans. FDG-PET has the potential to improve lymphoma patient management; however, its usefulness will likely vary by histology, stage, therapy, and clinical setting.
Similar articles
-
Impact of FDG-PET/CT in the management of lymphoma.Ann Nucl Med. 2011 Dec;25(10):701-16. doi: 10.1007/s12149-011-0549-0. Epub 2011 Oct 29. Ann Nucl Med. 2011. PMID: 22037934 Review.
-
PET/CT for therapy response assessment in lymphoma.J Nucl Med. 2009 May;50 Suppl 1:21S-30S. doi: 10.2967/jnumed.108.057190. Epub 2009 Apr 20. J Nucl Med. 2009. PMID: 19380407 Review.
-
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.J Nucl Med. 2007 Jan;48 Suppl 1:19S-27S. J Nucl Med. 2007. PMID: 17204717 Review.
-
The role of PET in lymphoma.J Nucl Med. 2006 Aug;47(8):1326-34. J Nucl Med. 2006. PMID: 16883013 Review.
-
The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.Ann Nucl Med. 2010 Nov;24(9):649-54. doi: 10.1007/s12149-010-0408-4. Epub 2010 Aug 26. Ann Nucl Med. 2010. PMID: 20740330
Cited by
-
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication.Mediterr J Hematol Infect Dis. 2015 Mar 1;7(1):e2015025. doi: 10.4084/MJHID.2015.025. eCollection 2015. Mediterr J Hematol Infect Dis. 2015. PMID: 25745552 Free PMC article.
-
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.Expert Rev Hematol. 2019 Nov;12(11):959-973. doi: 10.1080/17474086.2019.1660159. Epub 2019 Sep 12. Expert Rev Hematol. 2019. PMID: 31513757 Free PMC article. Review.
-
[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives.Cancers (Basel). 2018 May 18;10(5):145. doi: 10.3390/cancers10050145. Cancers (Basel). 2018. PMID: 29783621 Free PMC article. Review.
-
High Basal Maximal Standardized Uptake Value (SUVmax) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse.Cancers (Basel). 2021 Jun 9;13(12):2876. doi: 10.3390/cancers13122876. Cancers (Basel). 2021. PMID: 34207518 Free PMC article.
-
Pulmonary Findings of [18F]FDG PET/CT Images on Asymptomatic COVID-19 Patients.Pathogens. 2021 Jul 3;10(7):839. doi: 10.3390/pathogens10070839. Pathogens. 2021. PMID: 34357989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
